Hybrid device for cell therapies

• US 7,910,359 B2
• Filed: 07/20/2005
• Issued: 03/22/2011
• Est. Priority Date: 07/29/2004
• Status: Active Grant

• Current Assignee: University of Miami
• Original Assignee: University of Miami
• Inventors: Ricordi, Camillo
• Primary Examiner(s): Ford; Allison M
• Application Number:
  US11/185,011
• Publication Number:
  US 20060024276A1
• Time in Patent Office: 2,071 Days
• Field of Search: None
• US Class Current: 435/297.2
• CPC Class Codes: A61M 2202/097 endothelial cells
• CPC Class Codes: A61M 5/14244 adapted to be carried by the patient, e.g. portable on the body
• CPC Class Codes: A61M 5/14276 specially adapted for implantation

Abstract

A device for receiving implanted biological material includes a porous outer wall defining an inner space, a fluid manifold assembly for selectively infusing at least one of immunosuppressive and growth factor media to said space, and a pump structure operatively coupled to the manifold assembly. The device may comprise an additional plunger body for being disposed in said space and so as to define a peripheral gap between the plunger and the perforated wall of the device.

Claims

1. A device for receiving implanted biological material and configured for implantation into a patient, wherein said device comprises:

a) a porous outer wall defining an inner space, said inner space providing a receptacle for implanted biological material comprising a selected tissue/cell product, said inner space sized to receive 6,000 to 12,000 cells per kilogram of the weight of the patient, and said outer wall having a porosity which permits vasculature to reach the implanted biological material from outside the porous outer wall;

b) a fluid manifold assembly for selectively infusing at least one of immunosuppressive and/or growth factor media to said inner space, wherein said manifold assembly includes at least one longitudinally disposed media distribution conduit for distributing media to said inner space, and wherein microperforations along the length of said conduit compensate for a decrease in pressure along the length of the conduit in a direction away from the manifold for substantially uniform infusion and distribution of the media within said inner space; and

c) a pump or a reservoir for such media, operatively coupled to said manifold assembly.

2. A device as in claim 1, further comprising a removable plunger body for being disposed in said inner space so as to define a peripheral gap between the plunger and the outer wall.

3. A device as in claim 2, wherein said manifold assembly is formed separately from said plunger body, and said plunger body and said manifold assembly are selectively interchangeably placed within said inner space.

4. A device as in claim 2, wherein the plunger body and the manifold assembly are complementarily configured for simultaneous placement within the inner space.

5. A device as in claim 4, wherein said manifold assembly includes a closure cap.

6. A device as in claim 4, wherein there is a plurality of distribution conduits.

7. A device as in claim 4, wherein the manifold assembly and the plunger body are selectively inserted into said inner space from opposite longitudinal ends of said device.

8. A device as in claim 7, wherein the plunger body has built-in conduits operatively coupled to said pump or reservoir, wherein said conduits are capable of delivering a physiologic solution or a selected tissue/cell product to said inner space at the time of removal of the plunger, either to facilitate plunger displacement or to simultaneously load the selected cell product.

9. A device as in claim 8, wherein the built-in conduits of the plunger body are selectively positioned parallel and alternating with the conduits of the manifold assembly.

10. A device as in claim 1, wherein said manifold assembly includes a closure cap.

11. A device as in claim 1, wherein there is a plurality of distribution conduits.

12. A device as in claim 1, wherein the porous outer wall has first and second, generally parallel side walls.

13. A device as in claim 12, wherein said parallel side walls are curved.

14. A device as in claim 12, wherein the porous outer wall has third and fourth, convexly curved side walls.

25. A method for promoting the survival of biological material, comprising:

a) providing the device as in claim 1;

b) disposing a biological material comprising a selected tissue/cell product within said inner space; and

c) selectively infusing at least one of immunosuppressive and/or growth factor media to said inner space.

26. The method as in claim 25, wherein the method is ex vivo.

27. The method as in claim 26, further comprising allowing tissue ingrowth through said porous outer wall into said inner space.

28. The method as in claim 26, further comprising, before step b) disposing a biological material, step a′

) allowing tissue ingrowth through said porous outer wall into said inner space.

29. The method as in claim 28, wherein the device of claim 1 further comprises d) a removable plunger body within said inner space so as to define a peripheral gap between the plunger and the wall, such that said tissue ingrowth is into said peripheral gap.

30. The method as in claim 29, further comprising after step a′

) allowing tissue ingrowth, and before step b) disposing a biological material, step a″

) removing said plunger.

31. The method as in any one of claims 26-30, wherein said biological material is a biological factor producing biological material.

32. The method as in claim 25, wherein the method is in vivo, and wherein the method further comprises:

d) implanting said device at a selected location within a subject; and

e) allowing tissue ingrowth through said porous outer wall into said inner space.

33. The method as in claim 32, wherein said implanting comprises implanting said device in a location selected from the group consisting of intraomental, subcutaneous, and intraperitoneal.

34. The method as in claim 32, wherein the device of claim 1 further comprises d) a removable plunger body within said inner space so as to define a peripheral gap between the plunger and the wall, such that said tissue ingrowth is into said peripheral gap.

35. The method as in claim 34, further comprising a step e′

) removing said plunger, wherein step d) implanting said device, step e) allowing tissue ingrowth, and step e′

) removing said plunger occur before step b) disposing a biological material.

36. The method as in any one of claims 32-35, wherein said biological material is a biological factor producing biological material.

15. A method for implanting biological material in a patient, comprising:

a) providing a device for receiving biological material, said device comprising;

i) a porous outer wall defining an inner space, said inner space providing a receptacle for implanted biological material comprising a selected tissue/cell product, said inner space sized to receive 6,000 to 12,000 cells per kilogram of the weight of the patient, and said outer wall having a porosity which permits vasculature to reach the implanted biological material from outside the porous outer wall;

ii) a fluid manifold assembly for selectively infusing at least one of immunosuppressive and/or growth factor media to said inner space, wherein said manifold assembly includes at least one longitudinally disposed media distribution conduit for distributing media to said inner space, and wherein microperforations along the length of said conduit compensate for a decrease in pressure along the length of the conduit in a direction away from the manifold for substantially uniform infusion and distribution of the media within said inner space; and

iii) a pump or a reservoir for such media, operatively coupled to said manifold assembly;

b) implanting said device at a selected location within the patient;

c) allowing tissue ingrowth through said porous outer wall into said inner space;

d) disposing the biological material comprising a selected tissue/cell product within said inner space; and

e) selectively infusing at least one of immunosuppressive and/or growth factor media to said inner space.

16. A method as in claim 15, wherein said implanting comprises implanting said device in a location selected from the group consisting of intraomental, subcutaneous, and intraperitoneal.

17. A method as in claim 15, wherein the device further comprises iv) a removable plunger body within said inner space so as to define a peripheral gap between the plunger and the outer wall, such that said tissue ingrowth is into said peripheral gap.

18. A method as in claim 17, further comprising after step c) allowing tissue ingrowth, and before step d) disposing a biological material, a step c′

) removing said plunger.

19. A method as in claim 15, wherein step d) disposing a biological material precedes step b) implanting said device.

20. A method for implanting biological factor producing biological material in a patient, comprising:

a) providing a device for receiving biological factor producing biological material, said device comprising;

i) a porous outer wall defining an inner space, said inner space providing a receptacle for implanted biological material comprising a selected tissue/cell product, said inner space sized to receive 6,000 to 12,000 cells per kilogram of the weight of the patient, and said outer wall having a porosity which permits vasculature to reach the implanted biological material from outside the porous outer wall;

ii) a fluid manifold assembly for selectively infusing at least one of immunosuppressive and/or growth factor media to said inner space, wherein said manifold assembly includes at least one longitudinally disposed media distribution conduit for distributing media to said inner space, and wherein microperforations along the length of said conduit compensate for a decrease in pressure along the length of the conduit in a direction away from the manifold for substantially uniform infusion and distribution of the media within said inner space;

iii) a pump or a reservoir for such media, operatively coupled to said assembly; and

iv) a structure defining a path for the biological factor produced by said biological material to be conducted to the patient'"'"'s circulatory system;

b) implanting said device at a selected location within the patient;

c) disposing the biological factor producing biological material comprising a selected tissue/cell product within said inner space; and

d) selectively infusing at least one of immunosuppressive and/or growth factor media to said inner space using said assembly.

21. A method as in claim 20, further comprising, after step b) implanting said device, a step b′

) allowing tissue ingrowth through said porous outer wall into said inner space.

22. A method as in claim 21, wherein the device further comprises v) a removable plunger body within said inner space so as to define a peripheral gap between the plunger and the outer wall, such that said tissue ingrowth is into said peripheral gap.

23. A method as in claim 22, further comprising after step b′

) allowing tissue ingrowth, and before step c) disposing the biological factor producing biological material, a step b″

) removing said plunger.

24. A method as in claim 20, wherein step c) disposing the biological factor producing biological material precedes step b) implanting said device.